Study found the vaccine candidate produced a quick immune response but lower levels of antibodies than in recovered coronavirus patients.
China’s Sinovac reports mixed findings in early coronavirus vaccine trials
Study found the vaccine candidate produced a quick immune response but lower levels of antibodies than in recovered coronavirus patients.